Drug intelligence / Profile preview

Folic acid + Folinic acid

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular, Intrathecal
01

Overview

Folic acid and folinic acid are both forms of vitamin B9, essential for DNA synthesis, cell division, and growth. Folic acid is the synthetic form commonly used in supplements and food fortification. Folinic acid (also known as leucovorin or calcium folinate) is a reduced form of folic acid that does not require activation by dihydrofolate reductase to participate in cellular reactions. Folinic acid is primarily used as an antidote to counteract the toxic effects of antifolate drugs such as methotrexate and pyrimethamine by bypassing blocked metabolic steps, thus allowing normal cells to continue DNA synthesis even when dihydrofolate reductase is inhibited[1][3][4][5]. It also enhances the efficacy of fluorouracil (5-FU) chemotherapy by stabilizing its binding to thymidylate synthase, increasing cytotoxicity against cancer cells[2][4][6]. Both agents are used clinically—either alone or together—to reduce side effects from methotrexate therapy in conditions like rheumatoid arthritis or cancer treatment[8].

Brand names
Lederle LEUCOVORIN
Other names
calcium folinateleucovorincitrovorum factor5-formyl tetrahydrofolate
02

Targets

FOLR1 (FRα)DHFR (Dihydrofolate reductase)TS (Thymidylate synthase)

Beyond the preview

Go deeper on Folic acid + Folinic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folic acid + Folinic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call